HDAC9 and Carcinoma, Lewis Lung: More interestingly, FK228, a specific histone deacetylase (HDAC) inhibitor,47 has been reported to decrease hypoxia‐induced angiogenesis by suppression of HIF‐1α activity in Lewis lung carcinoma model.48